Hepatitis C virus treatment with glecaprevir and pibrentasvir in patients co-prescribed carbamazepine: Three case reports

BACKGROUND: Highly effective and well-tolerated direct-acting antiviral (DAA) therapies have revolutionised the management of hepatitis C virus (HCV); however, niche populations face treatment barriers. DAAs co-prescribed with several first-generation anti-epileptic drugs (AEDs) are contraindicated...

Descripción completa

Detalles Bibliográficos
Autores principales: Braude, Michael, Ratnam, Dilip T, Marsh, Louise, Abasszade, Joshua H, Dev, Anouk T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359723/
https://www.ncbi.nlm.nih.gov/pubmed/37484883
http://dx.doi.org/10.4292/wjgpt.v14.i4.33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359723/
https://www.ncbi.nlm.nih.gov/pubmed/37484883
http://dx.doi.org/10.4292/wjgpt.v14.i4.33

Ejemplares similares